TP53 and non-small cell lung carcinoma: Levobupivacaine inhibited the growth of gastric cancer cells through the miR-489-3p/SLC7A11 axis, leading to ferroptosis of cancer cells (114)while in non-small cell lung cancer cells, levobupivacaine up-regulated p53, inhibited the progression of NSCLC and induced ferroptosis (115).